Home >Newsletters >May 2001
 
ASA NEWSLETTER
 
 
May 2001
Volume 65
Number 5
   
Chemical Dependence in Anesthesiologists: What Is Being Done About It?

William P. Arnold III, M.D., Chair
Task Force on Chemical Dependence of the Committee on Occupational Health


On a rather fateful day in 1983, an extremely bright resident came to me saying, Bill, I'm in trouble I'm addicted to fentanyl. In an attempt to hide my astonishment, I responded, So what are you going to do about it? He had already arranged for admission to a fine treatment program, where he remained for four months before beginning his life of aftercare, in addition to continuing his career as an anesthesiologist. Although he has abstained from drug use for nearly two decades, relapse remains a constant threat for him as it does for all individuals in recovery.

That single experience served as a stimulus for me to gain insight into his misfortune. Over time, I have learned that while an understanding of the disease of addiction makes it possible for one to deal positively with an ill colleague, it is extremely difficult to prevent the disease from becoming manifest should an individual possess the roots that foster its development. Today, as it has for centuries, addiction parallels diseases such as malignancies, diabetes and a host of other sicknesses that are treatable but incurable.

In spite of fairly aggressive attempts by ASA and many other organizations to deal with the disease, it continues to plague anesthesiologists, primarily those in the early portions of their careers. Death as a result of drug overdose remains a tragic outcome in a disproportionate number of cases involving anesthesiologists. 1 It is my purpose in this article to summarize a variety of approaches being used to combat the disease.

Society of Academic Anesthesiology Chairs (SAAC) and Association of Anesthesiology Program Directors (AAPD):

In 1988, SAAC/AAPD devoted a major portion of a meeting to a series of presentations concerning chemical dependence in anesthesiologists. Since then, the disease has been a topic for discussion at nearly all its meetings. A major contribution was the funding of a videotape titled Wearing Masks, a moving presentation by the widow and friends of a resident in anesthesiology who died of an overdose of sufentanil. This tape, produced in 1992, is shown regularly to residents in anesthesiology as well as to their significant others. It can be obtained by contacting the ASA Executive Office.

Accreditation Council for Graduate Medical Education (ACGME)

Since 1992, ACGME has mandated that all residency programs in anesthesiology have a written policy for the management of chemical dependence in trainees. In addition, each program’s educational efforts must include presentations that address the disease as it relates to practitioners of the specialty.

American Board of Anesthesiology (ABA)

ABA will permit persons with a history of chemical dependence, who are satisfactorily recovering, to take both the written and oral examinations. After a candidate with this history has satisfied the requirements for certification, ABA will determine whether it should defer awarding its certification for a period of time in order to avoid certification of a candidate who poses a direct threat to the health and safety of others. If it deems such deferral appropriate, ABA will determine the length of time the candidate's certification is deferred following an individual assessment of the specific circumstances of the candidate’s history of alcohol abuse or illegal use of drugs. This is in keeping with the intent of the Americans with Disabilities Act.

Chief Residents’ Meetings

For several years (but ending in the mid-1990s), a pharmaceutical manufacturer hosted an annual meeting for chief residents in anesthesiology. Each meeting included presentations that focused on both the subjective and objective aspects of chemical dependence. This educational effort resulted in an awareness of the disease that has persisted in many of the attendees. It fostered an understanding in these persons that has facilitated assistance for addicted anesthesiologists in the United States and several other countries. It also served as groundwork for the formation of policies in many groups and departments.

American Society of Anesthesiologists (ASA)

1. Since 1983, the Annual Meetings of ASA have included panels and discussions on chemical dependence. Speakers have included not only members of the Society who have an interest in the disease but also experts in its treatment, persons in recovery, educators, an advisor to the President of the United States and the father of a resident who died of an overdose of fentanyl.

2. In a totally confidential manner, ASA has amassed 10 years of data on incidence and outcomes of chemical dependence in residency programs in the United States. Reviews of preliminary data have appeared in the ASA NEWSLETTER. Until recently, the strict confidentiality in which the data were collected and the departure of a key individual in that confidentiality process had made detailed analysis of the aggregate data difficult. Fortunately, that hurdle has been overcome, and anonymity for departments and individuals has been preserved. Publication of recent data will be forthcoming.

3. Since 1986, the ASA Committee on Occupational Health has published three brochures on chemical dependence. The most recent edition, published in 1998 and titled Chemical Dependence in Anesthesiologists: What you need to know when you need to know it, has appeared both in printed form and on the ASA Web Site at www.ASAhq.org/ProfInfo/chemical.html. With appearance of the latter, the material covered in the brochure has become available to a far greater audience than just the membership of the Society. As a result, calls for information and assistance are coming directly to the authors of the document from family members and friends of anesthesiologists. This is particularly heartening because were it not for the Web, most likely these persons would have remained unaware of the Society's interest in assisting its membership.

4. Since 1990, ASA has maintained a confidential hotline for persons who have questions or concerns regarding chemical dependence in themselves or others. Nearly 100 calls come annually either through the hotline or directly to members of the Committee on Occupational Health and its Task Force on Chemical Dependence. Questions have addressed such aspects of the disease as assistance with identification, intervention, referral for treatment, return to the workplace, disability and many others. With the appearance of the 1998 brochure on the Web, calls via the hotline have decreased somewhat.

5. The Task Force on Chemical Dependence and the Committee on Occupational Health are developing a curriculum on chemical dependence. This effort, which so far has taken several years, is nearly finished. When completed, the curriculum will be made available to SAAC/AAPD. We anticipate that it will serve as a model for residency programs to use in their training mandated by the Accreditation Council for Graduate Medical Education.

In spite of these various efforts, the incidence of the disease in anesthesiologists does not appear to have diminished significantly. At first glance, that would seem to imply that the efforts are ineffectual and perhaps should be abandoned. From a purely objective viewpoint, this may be true. But from the perspective of the individual or family member who has benefited from these services, those previous efforts may have been life-saving. For that reason alone, any diminution of these efforts would be a mistake.

Although education will not prevent the development of chemical dependence, it will certainly increase awareness and thus promote early identification and treatment. That conviction serves as the basis for recommending that this work be continued.

Reference:

1. Alexander BH, Checkoway H, Nagahama SI, Domino KB. Cause-specific mortality risks of anesthesiologists. Anesthesiology. 2000; 93:922-930.



  William P. Arnold III, M.D., is Associate Professor of Anesthesiology, University of Virginia Health System, Charlottesville, Virginia.


return to top


 


FEATURES

Chemical Dependence:
Exposing a Silent Enemy

ARTICLES


DEPARTMENTS


The views expressed herein are those of the authors and do not necessarily represent or reflect the views, policies or actions of the American Society of Anesthesiologists.

NL Archives

Information for Authors